LipiDiDiet is the longest randomized clinical trial in prodromal Alzheimer’s disease (AD) with a positive outcome conducted so far. Prodromal AD patients are on the ultimate stage before progressing to dementia. These patients, and their close partners, already realize that the mind deteriorates and memory, especially short-term memory, slowly but progressively fades. Despite intensive research, there is still no cure or disease modifying treatment available for prodromal AD. However, this early Alzheimer’s disease stage is considered to represent the best option for intervention.

Press realease